Spinout Active LTD

Company profile

Apex Molecular Limited

Home - Apex MolecularApex Molecular

We are a leading provider of specialist chemistry services to the pharmaceutical, biotechnology and applied chemistry sectors. Apex offers FFS and FTE contracts for bespoke custom synthesis and medicinal chemistry projects %

CRN
06596885
Founded
2008
Age
18

Overview

Browse spinouts
Legal name
APEX MOLECULAR LIMITED
Region
North West England
Registered address
BLOCK 19 ALDERLEY PARK
MERESIDE
ALDERLEY EDGE
CHESHIRE
ENGLAND
SK10 4TG
Insolvency history
No

Company events

Reference milestones and recent Companies House filing stream events.

6 events
28 Feb
2027

Accounts due

Accounts Due

Next accounts due date

09 Sep
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

26 Aug
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 May
2025

Accounts filed

Accounts

Last accounts made up date

07 Oct
2024

Accounts With Accounts Type Small

Accounts Analysed

AA | Transaction MzQzODU0OTg1N2FkaXF6a2N4

Published 07 Oct 2024 07:41

19 May
2008

Incorporated

Inception

Company registered at Companies House

Spinout profile

3 entries

Company description

Apex Molecular operates a laboratory and undertakes contracted synthetic chemistry jobs for clients in the pharmaceutical, biotechnology and applied chemical sectors.

SIC 20037310 - Research And Experimental Development On Natural Sciences And Engineering SIC 200772110 - Research And Experimental Development On Biotechnology Keywords biotechnology research & development natural science research & development research & development engineering research & development chemical substance development chemistry process technology scales pharmaceutical research hydrogenation customs

Project impact

Development of immobilised catalysts

Apex Molecular
2008
Apex Molecular
2008
YProTech
2008

Public funding

2 awards
First funded
2009
Funded years
2009, 2013
Age at first award
1 years

Projects

2013 Collaborative R&D Lead participant

Manufacture of chiral amines using catalytic and flow processing methods

1 Feb 2013 to 31 Jan 2015

Awarded
£62,500
Total cost £130,749

Chiral amines are important building blocks used in 40% pharmaceutical products, 20% of crop protection compounds and are high value chemical intermediates. Current synthetic methods use wasteful resolution processes. This project will improve manufacturing efficiency by developing catalytic (transfer) hydrogenation methods to make specific types of chira...

2009 Collaborative R&D Lead participant

CP-STAR - Tethered catylysts: Step-change high purity manufacture of high value pharmaceutical fine chemical and biotechnology products

1 Oct 2009 to 31 May 2013

Awarded
£188,666
Total cost £380,143

This industry-led project will enable new approaches to process chemistry based on advances in synthetic methods. The project investigates 'tethering' of new catalyst ligands to solid supports (such as polymer beads or porous surfaces) to prevent catalyst and reagent residues ending up in products and allow re-use and recycling. This also enables new, int...

Product types

Collaborative R&D